Evidence map›Paper›PMID 39033096›Full record

ArticleBMC microbiology2024

Optimization of fermentation parameters to improve the biosynthesis of selenium nanoparticles by Bacillus licheniformis F1 and its comprehensive application.

Zhangqian Wang, Nana Li, Xin Zhou, Shiya Wei, Ying Zhu, Mengjun Li, Jue Gong, Yi He, Xingxing Dong, Chao Gao and 1 more

Abstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhangqian Wang *National R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China.
Nana Li *National R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China.
Xin ZhouMedical Department of Gaoming Hospital of TCM, Foshan, 528500, China.
Shiya WeiNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China.
Ying ZhuNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China.
Mengjun LiNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China.
Jue GongHubei National Se-rich Technology Development Co., Ltd., Enshi, 445000, China.
Yi HeNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China.
Xingxing DongNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China. dongxingxinghg@163.com.
Chao GaoNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China. gaochao@whpu.edu.cn.
Shuiyuan ChengNational R&D Center for Se-rich Agricultural Products Processing, Wuhan, 430028, China. s_y_cheng@sina.com.

Funding

Doctoral Research Initiation Foundation of Wuhan Polytechnic University 2023RZ015Hubei Provincel Natural Science Foundation of China 2023AFB968Hubei Provincial Natural Science Foundation Project 2022CFB945
6 · The paper itself

Abstract

backgroundSelenium nanoparticles (SeNPs) are increasingly gaining attention due to its characteristics of low toxicity, high activity, and stability. Additionally, Bacillus licheniformis, as a probiotic, has achieved remarkable research outcomes in diverse fields such as medicine, feed processing, and pesticides, attracting widespread attention. Consequently, evaluating the activity of probiotics and SeNPs is paramount. The utilization of probiotics to synthesize SeNPs, achieving large-scale industrialization, is a current hotspot in the field of SeNPs synthesis and is currently the most promising synthetic method. To minimize production costs and maximize yield of SeNPs, this study selected agricultural by-products that are nutrient-rich, cost-effective, and readily available as culture medium components. This approach not only fulfills industrial production requirements but also mitigates the impact on downstream processes.

resultsThe experimental findings revealed that SeNPs synthesized by B. licheniformis F1 exhibited a spherical morphology with diameters ranging from 110 to 170 nm and demonstrating high stability. Both the secondary metabolites of B. licheniformis F1 and the synthesized SeNPs possessed significant free radical scavenging ability. To provide a more robust foundation for acquiring large quantities of SeNPs via fermentation with B. licheniformis F1, key factors were identified through single-factor experiments and response surface methodology (RSM) include a 2% seed liquid inoculum, a temperature of 37 ℃, and agitation at 180 rpm. Additionally, critical factors during the optimization process were corn powder (11.18 g/L), soybean meal (10.34 g/L), and NaCl (10.68 g/L). Upon validating the optimized conditions and culture medium, B. licheniformis F1 can synthesize nearly 100.00% SeNPs from 5 mmol/L sodium selenite. Subsequently, pilot-scale verification in a 5 L fermentor using the optimized medium resulted in a shortened fermentation time, significantly reducing production costs.

conclusionIn this study, the efficient production of SeNPs by the probiotic B. licheniformis F1 was successfully achieved, leading to a significant reduction in fermentation costs. The exploration of the practical applications of this strain holds significant potential and provides valuable guidance for facilitating the industrial-scale implementation of microbial synthesis of SeNPs.

Indexed as

Bacillus licheniformisCulture MediaFermentationProbioticsSeleniumMetal NanoparticlesNanoparticlesCulture MediaSeleniumBacillus licheniformisRSMSeNPsSodium selenite

Identifiers

PMID39033096
PMCPMC11264884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.